Abstract: The present invention provides compounds of Formula (I-IV): compositions containing the same, and methods of use thereof such as for the treatment of cancer.
Type:
Grant
Filed:
September 22, 2010
Date of Patent:
December 22, 2015
Assignees:
The University of North Carolina at Chapel Hill, National Taiwan University
Inventors:
Kuo-Hsiung Lee, Xiaoming Yang, Qian Shi, Kenneth F. Bastow, Che-Ming Teng, Tse-Ming Hong, Pan-Chyr Yang, Shuenn-Chen Yang
Abstract: A novel constrained peptide epitope derived from A?, wherein the eptitope comprises the amino acid sequence SNK, related antibody compositions and methods of use. An isolated antibody that specifically binds to a cyclic peptide comprising the conformational epitope which comprises the amino acid sequence SNK and corresponding to a solvent-exposed, antibody accessible knuckle region of oligomeric A? is described. An antigenic peptide comprising an epitope having a constrained cyclic configuration, which comprises the amino acid sequence SNK and corresponding to a solvent-exposed, antibody accessible knuckle region of oligomeric A? is also described. Methods of treating, preventing and diagnosing Alzheimer's disease are also described.
Abstract: Improved methods and systems for processing of solid tissue are described. The method may be performed manually or automatically. The system may have modules such as (i) a grossing module where a fresh tissue is sliced to prepare a tissue specimen, (ii) a hardening module that hardens the tissue specimen, (iii) an impregnating module that impregnates the tissue specimen that was hardened, and (iv) an embedding module that embeds a tissue specimen that was hardened and impregnated. Fresh (i.e., not fixed or frozen) tissue, which was excised to diagnose disease or to assess surgical treatment, is grossed to about 0.6 mm. Preferably, the hardening of fresh tissue is initiated, but not completed, during grossing by contact with a chemical admixture. Preferably, dry ice, a thermoelectric device, or a gas condenser cools a metal mold containing the embedded specimen.
Abstract: The invention provides for a nanostructure, or an array of such nanostructures, each comprising a rough surface, and a doped or undoped semiconductor. The nanostructure is an one-dimensional (1-D) nanostructure, such a nanowire, or a two-dimensional (2-D) nanostructure. The nanostructure can be placed between two electrodes and used for thermoelectric power generation or thermoelectric cooling.
Type:
Grant
Filed:
March 26, 2014
Date of Patent:
December 22, 2015
Assignee:
The Regents of The University of California
Abstract: A novel contrast mechanism for imaging blood flow using magneto-motive optical Doppler tomography (MM-ODT), Optical Coherence Tomography, and Ultrasound. MM-ODT, OCT, and ultrasound combined with an externally applied temporally oscillating high-strength magnetic field detects erythrocytes moving according to the field gradient.
Type:
Grant
Filed:
September 9, 2011
Date of Patent:
December 22, 2015
Assignee:
Board of Regents, The University of Texas System
Abstract: An apparatus and method of reconstructing a computed tomography (CT) image using multiple datasets of projective measurements, wherein the method of image reconstruction favors spatial correlations among the images respectively reconstructed from each of the corresponding multiple datasets. The multiple data sets each contain projective measurements of the same object taken in close temporal proximity, but taken with different detector type or configurations (e.g., different spectral components in spectral CT or different detector types in hybrid 3rd- and 4th-generation CT scanners). Reconstructed images minimizing a vectorial total variation norm satisfies the criteria of favoring images exhibiting spatial correlations among the reconstructed images and favoring a sparse gradient-magnitude image (i.e., edge enhancing image) for each reconstructed image.
Type:
Application
Filed:
June 16, 2014
Publication date:
December 17, 2015
Applicants:
The University of Chicago, Toshiba Medical Systems Corporation
Inventors:
David Rigie, Patrick La Riviere, Adam Petschke
Abstract: Disclosed is a membrane surface modification method. The method is applicable to a variety of hydrophobic membranes by doping selected inorganic particles. One act of the method involves the in-situ embedment of the inorganic particles onto the membrane surface by dispersing the particles in a non-solvent bath for polymer precipitation. Further membrane surface modification can be achieved by hydrothermally growing new inorganic phase on the embedded particles. The embedment of particles is for the subsequent phase growth.
Abstract: A microfluidic device comprising a plurality of reaction chambers in fluid communication with a flow channel formed in an elastomeric substrate, a vapor barrier for preventing evaporation from the plurality of reaction chambers, and a continuous phase fluid for isolation of each of the plurality of reaction chambers.
Type:
Grant
Filed:
November 7, 2008
Date of Patent:
December 15, 2015
Assignee:
The University of British Columbia
Inventors:
Carl Lars Genghis Hansen, Carolina Tropini
Abstract: A method for the manufacture of a polymer is provided, the method comprising: Providing a first monomer, the first monomer comprising a bicyclic diamine moiety, a first nucleophilic group provided on a carbon atom of an aromatic moiety, and a second nucleophilic group provided on a carbon atom of an aromatic moiety; Providing a bridging compound comprising at least two sites vulnerable to nucleophilic attack; and Contacting the first monomer with the bridging compound. Polymers made by said method and uses of such polymers are also disclosed.
Type:
Grant
Filed:
September 15, 2011
Date of Patent:
December 15, 2015
Assignee:
The University Court of the University of Edinburgh
Abstract: A clinical decision support system for patient treatment that incorporates patient data to display information in readily identifiable icons for vital organs and medical systems, and in a useable, real-time, updated fashion that extracts data from the medical history, the current medical management, the current physiologic monitors, and associated medical systems to produce warnings and alerts to enable caregivers to be made aware of physiologic systems at risk. These data are not only presented, but also use real-time queries and calculations to enable caregivers to have the types of data that would traditionally assist them in patient care but only be available by reviewing the medical literature and/or doing retrospective individual calculations while providing patient care.
Type:
Grant
Filed:
May 6, 2013
Date of Patent:
December 15, 2015
Assignee:
The Regents Of The University Of Michigan
Abstract: Methods are provided for the treatment of diseases and disorders using systematically-introduced nanoparticles to create a focused localized hyperthermia in a target area to enhance the effect of additional treatment therapies such as ionizing radiation. Advantages include an enhancement of the therapeutic effect of other therapies by increasing perfusion or reducing hypoxia in the treatment area, further, the methods herein may also result in the disruption of the vasculature, which provide further impetus for such treatments, singly and in combination with conventional therapies such as chemotherapy and radiation therapy.
Type:
Grant
Filed:
January 16, 2013
Date of Patent:
December 15, 2015
Assignees:
Nanospectra Biosciences, Inc., Board of Regents, The University of Texas System
Inventors:
Sunil Krishnan, Parmeswaran Diagaradjane, Jon Alexander Schwartz, James Chunjay Wang
Abstract: A quantum device is provided that includes controllably quantum mechanically coupled dangling bonds extending from a surface of a semiconductor material. Each of the controllably quantum mechanically coupled dangling bonds has a separation of at least one atom of the semiconductor material. At least one electrode is provided for selectively modifying an electronic state of the controllably quantum mechanically coupled dangling bonds. By providing at least one additional electron within the controllably quantum mechanically coupled dangling bonds with the proviso that there exists at least one unoccupied dangling bond for each one additional electron present, the inventive device is operable at least to 293 degrees Kelvin and is largely immune to stray electrostatic perturbations. Room temperature operable quantum cellular automata and qubits are constructed thereform.
Type:
Grant
Filed:
July 31, 2014
Date of Patent:
December 15, 2015
Assignees:
National Research Council of Canada, The Governors of The University of Alberta
Inventors:
Gino A. Dilabio, Robert A. Wolkow, Jason L. Pitters, Paul G. Piva
Abstract: An apparatus and method for calculating athlete speed non-invasively, on the field/court of play using data from a torso-mounted inertial measurement unit. The method complements existing, GPS-based methods for calculating athlete speed by enabling use in environments where GPS signal is unavailable (i.e. indoors).
Type:
Grant
Filed:
March 25, 2014
Date of Patent:
December 15, 2015
Assignee:
The Regents Of The University Of Michigan
Abstract: The present invention generally relates to a device and method for the management of a collection of battery cells. In one embodiment, the present invention permits the management of a collection of battery cells composed of an overall battery pack manager unit, individual cell manager units, and wireless communication links between these units. In another embodiment, the present invention relates to a device and method for the management of a collection of battery cells in the field of rechargeable batteries, such as batteries based on lithium-based chemistries, nickel-based chemistries, and lead-acid chemistries. In still another embodiment, the present invention is directed to a method that permits the maximization of battery pack capacity during a charge-discharge cycle and/or permits the maximization of the total number of charge-discharge cycles.
Type:
Grant
Filed:
April 6, 2010
Date of Patent:
December 15, 2015
Assignee:
The University of Akron
Inventors:
Thomas T. Hartley, Benjamin W. Magistro, Courtney A. Gras, Rick Clester, Andrew Faulstick
Abstract: The present invention concerns methods and compositions for treating or preventing a bacterial infection, particularly infection by a Staphylococcus bacterium. The invention provides methods and compositions for stimulating an immune response against the bacteria. In certain embodiments, the methods and compositions involve a non-toxigenic Protein A (SpA) variant or an antibody directed thereto.
Type:
Grant
Filed:
July 18, 2014
Date of Patent:
December 15, 2015
Assignee:
The University of Chicago
Inventors:
Olaf Schneewind, Alice Cheng, Dominique M. Missiakas, Hwan Keun Kim
Abstract: The present invention relates to an iridium-based catalyst compound for hydrogenating reducible moieties, especially imines and iminiums, the catalyst compounds being defined by the formulas: where ring B is either itself polycyclic, or ring B together with R is polycyclic. The catalysts of the invention are particularly effective in reductive amination procedures 10 which involve the in situ generation of the imine or iminium under reductive hydrogenative conditions.
Type:
Grant
Filed:
April 15, 2013
Date of Patent:
December 15, 2015
Assignee:
The University of Liverpool
Inventors:
Dinesh Talwar, Weijun Tang, Chao Wang, Barbara Villa Marcos, Jianliang Xiao
Abstract: A photovoltaic device includes an electron accepting material and an electron donating material. One of the electron accepting or donating materials is configured and dimensioned as a first component of a bulk heterojunction with a predetermined array of first structures, each first structure is substantially equivalent in three dimensional shape, has a substantially equivalent cross-sectional dimension, and where each first structure of the array of first structures has a substantially equivalent orientation with respect to adjacent first structures of the predetermined array forming a substantially uniform array.
Type:
Grant
Filed:
March 6, 2013
Date of Patent:
December 15, 2015
Assignee:
The University of North Carolina at Chapel Hill
Inventors:
Joseph M. DeSimone, Ginger Denison Rothrock, Zhilian Zhou, Edward T. Samulski, Meredith Earl, Stuart Williams
Abstract: An embodiment of the present invention is an imaging arrangement that includes imaging optics, a fiducial light source, and a control system. In operation, the imaging optics separate light into first and second tight by wavelength and project the first and second light onto first and second areas within first and second detector regions, respectively. The imaging optics separate fiducial light from the fiducial light source into first and second fiducial light and project the first and second fiducial light onto third and fourth areas within the first and second detector regions, respectively. The control system adjusts alignment of the imaging optics so that the first and second fiducial light projected onto the first and second detector regions maintain relatively constant positions within the first and second detector regions, respectively. Another embodiment of the present invention is a microscope that includes the imaging arrangement.
Type:
Grant
Filed:
December 1, 2009
Date of Patent:
December 15, 2015
Assignee:
The Regents of The University of California
Abstract: In some embodiments, the methods involve the use of a combination of at least two of the following: an inhibitor of indoleamine-2,3-dioxygenase (IDO), an inhibitor of the PD-L1/PD-1 pathway, an inhibitor of CTLA-4, an inhibitor of CD25, or IL-7. The inventors particularly observed a major synergistic effect of combining anti-CTLA-4 with either an IDO inhibitor, with anti-PD-L1 mAb, or with CD-25 depletion. Such combinations have been found to demonstrate a synergistic effect in treating cancer and tumors, for example by reducing tumor size, increasing the percentage of antigen-specific T cells, and increasing T cell function.
Type:
Application
Filed:
October 25, 2013
Publication date:
December 10, 2015
Applicant:
The University of Chicago
Inventors:
Thomas F. Gajewski, Stefani Spranger, Michael Leung
Abstract: An MOCVD system fabricates high quality superconductor tapes with variable thicknesses. The MOCVD system can include a gas flow chamber between two parallel channels in a housing. A substrate tape is heated and then passed through the MOCVD housing such that the gas flow is perpendicular to the tape's surface. Precursors are injected into the gas flow for deposition on the substrate tape. In this way, superconductor tapes can be fabricated with variable thicknesses, uniform precursor deposition, and high critical current densities.